The Authors thus concluded that NK-cell-mediated control of SARS-CoV-2 replication in infected target cells requires redundant recognition by activating NK cell receptors, while this process was impaired in infected cells treated with NK cells isolated from patients admitted to hospital with COVID-19. This evidence concerns the gene KLRD1 and COVID-19.